Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.32909 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.22585 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.23048 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.12142 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.14114 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.39164 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.43472 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.26181 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.22152 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18949 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.23209 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16129 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.25623 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.23074 | 51 |